Related content

Minimal Benefit to Subsequent Intraoperative Parathyroid Hormone Testing After All Four Glands Have Been Identified

By Ahmed Kamal   Alhefdhi Amal   Schneider David   Ojomo Kristin   Sippel Rebecca   Chen Herbert   Mazeh Haggi  

Annals of Surgical Oncology, Vol. 20, Iss. 13, 2013-12 ,pp. : 4200-4204

Springer Publishing Company

Access to resources Recommend Favorite

Phase 2 Trial of Single Agent Ifosfamide/Mesna in Patients with Platinum/Paclitaxel Refractory Ovarian Cancer Who Have Not Previously Been Treated with an Alkylating Agent

By Markman M.   Kennedy A.   Sutton G.   Hurteau J.   Webster K.   Peterson G.   Kulp B.   Belinson J.  

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 272-274

Elsevier

Access to resources Recommend Favorite

The Value of Multi-Modal Gene Screening in HNPCC in Quebec: Three Mutations in Mismatch Repair Genes that would have not been Correctly Identified by Genomic DNA Sequencing Alone

By McVety Susan   Li Lili   Thiffault Isabelle   Gordon Philip   MacNamara Elizabeth   Wong Nora   Australie Karlene   Kasprzak Lidia   Chong George   Foulkes William  

Familial Cancer, Vol. 5, Iss. 1, 2006-03 ,pp. : 21-28

Springer Publishing Company

Access to resources Recommend Favorite

Has Progress Been Made in Gastrointestinal Cancer Treatment?

By Glimelius Bengt  

Acta Oncologica, Vol. 41, Iss. 2, 2002-04 ,pp. : 115-117

Informa Healthcare

Access to resources Recommend Favorite

Frozen cones: they have a niche

By Hannigan E.V.  

Gynecologic Oncology, Vol. 91, Iss. 2, 2003-11 ,pp. : 279-279

Elsevier

Access to resources Recommend Favorite